Joseph J Skitzki
Overview
Explore the profile of Joseph J Skitzki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Powers C, Fisher D, Ku A, Neznanov N, Safina A, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518148
Background: Surgery, chemotherapy, and radiation often have limited utility for advanced metastatic disease in the liver, and despite its promising activity in select cancers, PD-1 blockade therapy similarly has minimal...
2.
Gabriel E, Sukniam K, Popp K, Kowkabany G, Manaise H, Attwood K, et al.
Clin Transl Med
. 2024 Apr;
14(4):e1633.
PMID: 38616706
No abstract available.
3.
Benesch M, Skitzki J
Melanoma Res
. 2023 Nov;
34(1):16-21.
PMID: 37924527
Invasive cutaneous melanoma is the most lethal skin cancer, but fortunately, the vast majority can be surgically treated with wide local excision, and sometimes additionally with sentinel or index lymph...
4.
5.
Alaklabi S, Roy A, Skitzki J, Iyer R
Mol Clin Oncol
. 2023 Mar;
18(4):31.
PMID: 36908980
Over the last decade, there has been a movement in cancer treatment away from cytotoxic therapies toward strategies that enhance the immune system against cancer. Immune checkpoint inhibitors (ICIs) have...
6.
Kim M, Fisher D, Bogner P, Sharma U, Yu H, Skitzki J, et al.
Clin Transl Med
. 2022 Aug;
12(8):e996.
PMID: 35994413
Background: Vascularized composite tissue allotransplantation (VCA) to replace limbs or faces damaged beyond repair is now possible. The resulting clear benefit to quality of life is a compelling reason to...
7.
Vaghjiani R, Skitzki J
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954412
Since its first application in the treatment of cancer during the 1800s, immunotherapy has more recently become the leading edge of novel treatment strategies. Even though the efficacy of these...
8.
Wach M, Subjeck J, Wang X, Repasky E, Matsuzaki J, Yu H, et al.
Melanoma Res
. 2022 Mar;
32(2):88-97.
PMID: 35254331
Heat shock proteins (hsp) are intracellular chaperones that possess extracellular immunostimulatory properties when complexed with antigens. A recombinant Hsp110-gp100 chaperone complex vaccine showed an antitumor response and prolonged survival in...
9.
Switzer B, Puzanov I, Skitzki J, Hamad L, Ernstoff M
JCO Oncol Pract
. 2022 Feb;
18(5):335-351.
PMID: 35133862
Cutaneous melanoma remains the most lethal of the primary cutaneous neoplasms, and although the incidence of primary melanoma continues to rise, the mortality from metastatic disease remains unchanged, in part...
10.
Peng J, LaPiano J, Wang K, Attwood K, Skitzki J, Kane 3rd J, et al.
Ann Surg Oncol
. 2021 Aug;
29(1):163-173.
PMID: 34383185
Background: Management of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) has historically favored liberal fluid administration owing to lengthy duration of surgery and hyperthermia. This practice has been...